Clinical Trial Update: Nivolumab Combined With SOX Used in the Perioperative Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating nivolumab plus the SOX regimen as perioperative treatment for gastric cancer. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)
• nivolumab (nivolumab)

Snippet

Sponsor: Xiangdong Cheng | Conditions: Immune Suppression, Gastric Cancer | Phase 2 | Status: RECRUITING